Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : FP01
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Consegna Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Consegna Pharma Acquires Fathom Pharma to Strengthen Initiatives that Address the Opioid Crisis
Details : Fathom joining Consegna, will accelerate the clinical development of combined LAI (long-acting injectables) focused on several aspects of pain signaling pathways. Fathom Pharma develops new treatments for chronic pain that includes FP01, as a treatment ...
Brand Name : FP01
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 19, 2022
Lead Product(s) : FP01
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Consegna Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?